Sub-Q Bionics

Company Overview

Snapshot

Founded in February 2025, Sub-Q Bionics operates with 1–10 employees. The company has raised $1.5M across one funding round. In March 2026, Sub-Q Bionics secured seed funding to advance its implantable fluid management device.

Business overview

Sub-Q Bionics is a Health Tech & Life Sciences company developing an implantable device designed for lymphedema patients. This core technology provides continuous fluid management, offering an alternative to daily compression therapy. The company operates within the medical devices sector, specifically focusing on medical treatment and therapeutics, and serves the broader healthcare and life sciences industries.

Company Intelligence Q&A

What is Sub-Q Bionics' primary focus?

Sub-Q Bionics is developing an implantable device designed to provide continuous fluid management for lymphedema patients, aiming to replace the need for daily compression therapy.

When was Sub-Q Bionics founded?

Sub-Q Bionics was founded in February 2025.

What is the current employee size of Sub-Q Bionics?

Sub-Q Bionics currently has 1–10 employees.

What is Sub-Q Bionics' current product development stage?

Sub-Q Bionics' product is currently in the R&D stage, focusing on developing an implantable device for lymphedema patients.

What is the total capital raised by Sub-Q Bionics?

Sub-Q Bionics has raised a total of $1.5M in funding.